Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Prevention

ACIP: 2020 Child and Adolescent Immunization Schedule Updates

Diana Ernst, RPh

February 12, 2020

The ACIP has released an updated version of the child and adolescent immunization schedule for ages 18 years and younger in the United States.

Lung Infection

FDA Authorizes Use of Coronavirus Test at CDC-Qualified US Lab

Diana Ernst, RPh

February 10, 2020

The FDA has issued an emergency use authorization that would allow the use of the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel by any CDC-qualified lab across the US.

Influenza

FDA Approves Novel Influenza A (H5N1) Vaccine

Diana Ernst, RPh

February 6, 2020

The FDA has approved the influenza A H5N1 vaccine for active immunization in patients 6 months of age and older with increased risk of exposure.

Overdoses Related to Heroin Tripled in Three-Year Period

Lung Infection

CDC: Guidance for Novel Coronavirus Updated as More Cases Confirmed

Diana Ernst, RPh

February 5, 2020

There are 11 confirmed cases of 2019 novel coronavirus in the US as of February 3, 2020 according to the Centers for Disease Control and Prevention (CDC).

Lung Infection

WHO Declares Coronavirus Global Emergency; First Person-to-Person Spread in US

Diana Ernst, RPh

February 1, 2020

The first instance of person-to-person spread of the 2019 novel coronavirus (2019-nCov) has been confirmed in the US, according to the CDC.

Lung Infection

Additional Cases of 2019 Novel Coronavirus in the United States

Diana Ernst, RPh

January 29, 2020

Additional cases of 2019 Novel Coronavirus (2019-nCov) have been confirmed in the US, bringing the total number of cases to 5.

General Pulmonology

FDA: Cases of Respiratory Depression With Gabapentinoids Reported

Diana Ernst, RPh

December 27, 2019

The FDA is requiring new warnings be added to the prescribing information for gabapentinoids about the risk of respiratory depression.

Pneumonia

ACIP: Pneumococcal Vaccine Recs Updated in Patients 65 Years and Older

Diana Ernst, RPh

November 26, 2019

The decision to update the pneumococcal vaccine recommendations was based on a review of evidence that demonstrated that the implementation of the 2014 recommendation had minimal impact on PCV13-type disease at the population level among older adults.